CRO concept continues to strengthen, Zhongyan Pharma hits limit up.

CRO concept continues to strengthen, as of the time of this writing, Meidixi's stock has risen by over 15%, Zhaoyan New Medicine has hit the limit up, and stocks of Kanglong Huacheng, Boteng shares, Kailaiying and others are also following the trend.